Pore Worms: Using Caenorhabditis Elegans to Study How Bacterial Toxins Interact with Their Target Host
Overview
Affiliations
The interaction of pathogenic bacteria with a target host is regulated both by bacterial virulence factors and by host components that either protect the host or that promote pathogenesis. The soil nematode Caenorhabditis elegans is a host for a number of bacterial pathogens, as briefly reviewed here. Bacillus thuringiensis (Bt) is a pathogenic bacteria that C. elegans is likely to encounter naturally in the soil. The pore-forming Crystal (Cry) toxins made by Bt are recognized as the dominant virulence factor in this host-pathogen interaction. Forward genetic screens for C. elegans mutants resistant to the Cry toxin, Cry5B, have identified a host carbohydrate structure that promotes pathogenesis. Data suggest this structure is likely to be a Cry5B receptor expressed in the host intestine. This finding is discussed in light of other carbohydrate receptors for bacterial toxins. To investigate host-toxin interactions on a global level, the response of C. elegans to the pore-forming Cry5B is also being investigated by gene transcription profiling (microarrays). These data are beginning to reveal a diverse intracellular response to toxin exposure. To put these investigations in perspective, host responses to other pore-forming toxins are discussed. Investigations with Cry5B in C. elegans show a promising beginning in helping to elucidate host-toxin and host-pathogen interactions.
Williams P, Brewer M, Aroian R, Robertson A, Martin R PLoS Pathog. 2024; 20(5):e1011835.
PMID: 38758969 PMC: 11139322. DOI: 10.1371/journal.ppat.1011835.
Sitaram A, Yin Y, Zamaitis T, Zhang B, Aroian R PLoS Pathog. 2022; 18(11):e1010656.
PMID: 36374839 PMC: 9704757. DOI: 10.1371/journal.ppat.1010656.
Proteomic analysis of Caenorhabditis elegans against Salmonella Typhi toxic proteins.
Mir D, Balasubramaniam B, VenkataKrishna L, Muthubharathi B, Balamurugan K Genes Immun. 2021; 22(2):75-92.
PMID: 33986511 DOI: 10.1038/s41435-021-00132-w.
Goswamy D, Irazoqui J Curr Opin Immunol. 2020; 68:9-20.
PMID: 32898751 PMC: 7925333. DOI: 10.1016/j.coi.2020.08.002.
Shi J, Peng D, Zhang F, Ruan L, Sun M PLoS Pathog. 2020; 16(5):e1008501.
PMID: 32369532 PMC: 7228132. DOI: 10.1371/journal.ppat.1008501.